Franklin Resources’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9M | Buy |
666,466
+175,346
| +36% | +$5.49M | 0.01% | 914 |
|
|
2025
Q1 | $16.5M | Sell |
491,120
-84,470
| -15% | -$2.83M | ﹤0.01% | 952 |
|
|
2024
Q4 | $22.6M | Buy |
575,590
+9,675
| +2% | +$379K | 0.01% | 864 |
|
|
2024
Q3 | $23.6M | Sell |
565,915
-12,950
| -2% | -$541K | 0.01% | 843 |
|
|
2024
Q2 | $22.6M | Buy |
578,865
+36,576
| +7% | +$1.43M | 0.01% | 816 |
|
|
2024
Q1 | $23.3M | Buy |
542,289
+248,464
| +85% | +$10.7M | 0.01% | 816 |
|
|
2023
Q4 | $13.5M | Buy |
293,825
+121,213
| +70% | +$5.58M | 0.01% | 859 |
|
|
2023
Q3 | $5.9M | Hold |
172,612
| – | – | ﹤0.01% | 1042 |
|
|
2023
Q2 | $6.65M | Buy |
172,612
+3
| +0% | +$116 | ﹤0.01% | 1032 |
|
|
2023
Q1 | $6.18M | Buy |
+172,609
| New | +$6.18M | ﹤0.01% | 1047 |
|